Literature DB >> 2968880

Insulin requirement in non-insulin-dependent diabetes mellitus: relation to simple tests of islet B-cell function and insulin sensitivity.

H J Gjessing1, L E Matzen, P C Pedersen, O K Faber, A Frøland.   

Abstract

Evaluation of simple tests of islet B-cell function and insulin sensitivity as predictors of metabolic control was performed during 3 months of insulin withdrawal in 25 insulin-treated diabetic subjects. All patients had a glucagon stimulated plasma C-peptide concentration above 0.33 nmol/l and a fasting plasma C-peptide concentration above 0.20 nmol/l a few days before insulin withdrawal. Insulin sensitivity was measured as the glucose disappearance rate (k) during an intravenous insulin tolerance test. Two patients were considered insulin-requiring due to high fasting blood glucose levels (greater than 20 mmol/l) and two patients due to an increase in glycosylated haemoglobin of more than 1.1% (greater than approximately 3SD) in combination with weight loss. None of the remaining patients had a significant increase in glycosylated haemoglobin. An inverse correlation was found between stimulated C-peptide levels and insulin sensitivity (r = 0.41, p less than 0.05). Fasting and stimulated C-peptide concentrations of 0.40 and 0.70 nmol/l, respectively, separated non-insulin-requiring patients from a group consisting of both insulin- and non-insulin-requiring patients. At these C-peptide levels the predictive value of a positive test was 100% while the predictive value of a negative test was as low as 33% or 27% depending on whether fasting or stimulated C-peptide concentration was used. Including the k value in the prediction only increased the predictive values of negative tests to 40% and 33%, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968880     DOI: 10.1111/j.1464-5491.1988.tb00999.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

1.  A simple clinical approach to discriminate between "true" and "pseudo" secondary failure to oral hypoglycaemic agents.

Authors:  L Scionti; P Misericordia; A Santucci; F Santeusanio; P Brunetti
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

2.  The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.

Authors:  H J Gjessing; B Reinholdt; O Pedersen
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

Review 3.  Latent autoimmune diabetes in adults (LADA) should be less latent.

Authors:  S Fourlanos; F Dotta; C J Greenbaum; J P Palmer; O Rolandsson; P G Colman; L C Harrison
Journal:  Diabetologia       Date:  2005-09-29       Impact factor: 10.122

4.  Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.

Authors:  H J Gjessing; L E Matzen; O K Faber; A Frøland
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

5.  A case of pheochromocytoma complicated with slowly progressive type 1 diabetes mellitus and chronic thyroiditis.

Authors:  Koji Murao; Hitomi Imachi; Makoto Sato; Hiroaki Dobashi; Ritsuya Tahara; Reiji Haba; Yoshiyuki Kakehi; Toshihiko Ishida
Journal:  Endocrine       Date:  2008-02-07       Impact factor: 3.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.